U.S. Markets closed
  • S&P 500

    3,911.74
    +116.01 (+3.06%)
     
  • Dow 30

    31,500.68
    +823.32 (+2.68%)
     
  • Nasdaq

    11,607.62
    +375.43 (+3.34%)
     
  • Russell 2000

    1,765.74
    +54.06 (+3.16%)
     
  • Crude Oil

    107.06
    +2.79 (+2.68%)
     
  • Gold

    1,828.10
    -1.70 (-0.09%)
     
  • Silver

    21.13
    +0.09 (+0.42%)
     
  • EUR/USD

    1.0559
    +0.0034 (+0.3273%)
     
  • 10-Yr Bond

    3.1250
    +0.0570 (+1.86%)
     
  • Vix

    27.23
    -1.82 (-6.27%)
     
  • GBP/USD

    1.2270
    +0.0009 (+0.0736%)
     
  • USD/JPY

    135.2100
    +0.2770 (+0.2053%)
     
  • BTC-USD

    21,104.67
    +113.38 (+0.54%)
     
  • CMC Crypto 200

    462.12
    +8.22 (+1.81%)
     
  • FTSE 100

    7,208.81
    +188.36 (+2.68%)
     
  • Nikkei 225

    26,491.97
    +320.72 (+1.23%)
     

Liquid Biopsy Market to reach USD 21.27 Billion by 2030, at a Compound Annual Growth Rate (CAGR) of 14.89% - MDC Research

·7 min read
Market Data Centre
Market Data Centre

Companies Covered F. Hoffmann-La Roche Ltd. (Switzerland), Myriad Genetics, Inc. (US), QIAGEN N.V. (Netherlands), Thermo Fisher Scientific, Inc. (US), Guardant Health, Inc. (US), MDxHealth SA (Belgium), Exact Sciences Corporation (US), Illumina Inc. (US), Sysmex Inostics (US), Bio-Rad Laboratories, Inc. (US), Biocept, Inc. (US), NeoGenomics, Inc. (US), ANGLE plc (UK), Menarini-Silicon Biosystems (Italy), Vortex Biosciences, Inc. (US), Exosome Diagnostics, Inc. (US), Agena Bioscience, Inc. (US), MedGenome Inc. (US), Epigenomics AG (Germany), Personal Genome Diagnostics, Inc. (US)., among others.

Pune, June 22, 2022 (GLOBE NEWSWIRE) -- Liquid Biopsy Market  by Vendor Assessment, Technology Assessment, Partner & Customer Ecosystem, type/solution, service, organization size, end-use verticals, and Region – Global Liquid Biopsy Market  Forecast to 2030, published by Market Data Centre, The Liquid Biopsy Market  is projected to grow at a solid pace during the forecast period. The presence of key players in the ecosystem has led to a compsetitive and diverse market. The advancement of digital transformation initiatives across multiple industries is expected to drive the worldwide Liquid Biopsy Market  during the study period.

This COVID-19 analysis of the report includes COVID-19 IMPACT on the production and, demand, supply chain. This report provides a detailed historical analysis of the global Liquid Biopsy Market  from 2017-to 2021 and provides extensive market forecasts from 2022-to 2030 by region/country and subsectors. The report covers the revenue, sales volume, price, historical growth, and future perspectives in the Liquid Biopsy Market .

The Global Liquid Biopsy Market size is projected to grow from USD 8.45 Billion in 2022 to USD 21.27 Billion by 2030, at a Compound Annual Growth Rate (CAGR) of 14.89% during the forecast period (2022-2030).

Download Free Sample PDF@ https://www.marketdatacentre.com/samplepdf/13497    


 List of the key players of the global liquid biopsy market profiled are:

  • QIAGEN

  • Myriad Genetics, Inc.

  • BIOCEPT, Inc.

  • Guardant Health, Inc.

  • F. Hoffmann-La Roche Ltd.

  • Illumina, Inc.

  • Angle plc

  • Oncimmune

  • Thermo Fisher Scientific, Inc.

  • Lucence health Inc.

  • FreenomeHoldings, Inc.

  • EPIGENOMICS AG

  • Among others.


Regional Analysis:

On the basis of Geography, the Global Liquid Biopsy Market  is segmented into North America, Europe, Asia-Pacific, and the Rest of the World (RoW). North America is expected to hold a considerable share in the global Liquid Biopsy Market . Due to increasing investment for research and development process and adoption of solutions in the region whereas Asia-Pacific is expected to grow at a faster pace during the forecasted period.

The growing number of Liquid Biopsy Market  players across regions is expected to drive market growth further. Moreover, increasing investments by prominent vendors in product capabilities and business expansion is expected to fuel the market during the study period. Many market players are finding lucrative opportunities in emerging economies like China and India, where the large populations are coupled with new innovations in numerous industries.

Market Assessment

Technology Assessment

Vendor Assessment

Market Dynamics

Key Innovations

Product Breadth and Capabilities

Trends and Challenges

Adoption Trends and Challenges

Technology Architecture

Drivers and Restrains

Deployment Trends

Competitive Differentiation

Regional and Industry Dynamics

Industry Applications

Price/Performance Analysis

Regulations and Compliance

 

Strategy and Vision


In deep ToC includes

233 – Tables

45  – Figures

300 – Pages


Get Table Of Content of the Report @ https://www.marketdatacentre.com/toc/13497  


Table of Contents                                                                           

1.      INTRODUCTION
1.1.   Market Definition
1.2.   Market Segmentation
1.3.   Geographic Scope
1.4.   Years Considered: Historical Years – 2017 & 2020; Base Year – 2021; Forecast Years – 2022 to 2030
1.5.   Currency Used
2.      RESEARCH METHODOLOGY
2.1.   Research Framework
2.2.   Data Collection Technique
2.3.   Data Sources
2.3.1.      Secondary Sources
2.3.2.      Primary Sources
2.4.   Market Estimation Methodology
2.4.1.      Bottom-Up Approach
2.4.2.      Top-Down Approach
2.5.   Data Validation and Triangulation
2.5.1.      Market Forecast Model
2.5.2.      Limitations/Assumptions of the Study
3.      ABSTRACT OF THE STUDY
4.      MARKET DYNAMICS ASSESSMENT
4.1.   Overview
4.2.   Drivers
4.3.   Barriers/Challenges
4.4.   Opportunities
5.      VALUE CHAIN ANALYSIS
6.      PRICING ANALYSIS
7.      SUPPLY CHAIN ANALYSIS
8.      MARKET SIZING AND FORECASTING
8.1.   Global - Liquid Biopsy Market  Analysis & Forecast, By Region
8.2.   Global - Liquid Biopsy Market  Analysis & Forecast, By Segment
8.2.1.      North America Liquid Biopsy Market , By Segment
8.2.2.      North America Liquid Biopsy Market , By Country
8.2.2.1.            US
8.2.2.2.            Canada
8.2.3.      Europe Liquid Biopsy Market , By Segment
8.2.4.      Europe Liquid Biopsy Market , By Country
8.2.4.1.            Germany
8.2.4.2.            UK
8.2.4.3.            France
8.2.4.4.            Rest of Europe (ROE)
8.2.5.      Asia Pacific Liquid Biopsy Market , By Segment
8.2.6.      Asia Pacific Liquid Biopsy Market , By Country
8.2.6.1.            China
8.2.6.2.            Japan
8.2.6.3.            India
8.2.6.4.            Rest of Asia Pacific (RoAPAC)
8.2.7.      Rest of the World (ROW) Liquid Biopsy Market , By Segment
8.2.8.      Rest of the World (ROW) Liquid Biopsy Market , By Country
8.2.8.1.            Latin America
8.2.8.2.            Middle East & Africa

ToC can be modified as per clients' business requirements*


Read Overview of the Report @ https://www.marketdatacentre.com/liquid-biopsy-market-13497

                       

Key Questions Answered in This Report:

  • How does our product and services portfolio compare to leading competitors?

  • What are the key developments in customer demand given the changing economy?

  • What are the new pricing and consumption models in the marketplace and how should we align our portfolio?

  • What are the key decision drivers for services buyers?

  • How can we accelerate our bidding process?

  • What is the potential of the Liquid Biopsy Market ?

  • What is the impact of COVID-19 on the global Liquid Biopsy Market ?

  • What are the top strategies that companies adopting in Liquid Biopsy Market ?

  • What are the challenges faced by SME’s and prominent vendors in Liquid Biopsy Market ?

  • Which region has the highest investments in Liquid Biopsy Market ?

  • What are the latest research and activities in Liquid Biopsy Market ?

  • Who are the prominent players in Liquid Biopsy Market ?

  • What is the potential of the Liquid Biopsy Market ?

Vendor Assessment

Vendor assessment includes a deep analysis of how vendors are addressing  the demand in the Liquid Biopsy Market . The MDC CompetetiveScape model was used to assess qualitative and quantitative insights in this assessment. MDC's CompetitiveScape is a structured method for identifying key players and outlining their strengths, relevant characteristics, and outreach strategy. MDC's CompetitiveScape allows organizations to analyze the environmental factors that influence their business, set goals, and identify new marketing strategies. MDC Research analysts conduct a thorough investigation of vendors' solutions, services, programs, marketing, organization size, geographic focus, type of organization and strategies.

Technology Assessment

Technology dramatically impacts business productivity, growth and efficiency.Technologies can help companies develop competitive advantages, but choosing them can be one of the most demanding decisions for businesses. Technology assessment helps organizations to understand their current situation with respect to technology and offer a roadmap where they might want to go and scale their business. A well-defined process to assess and select technology solutions can help organizations reduce risk, achieve objectives, identify the problem, and solve it in the right way. Technology assessment can help businesses identify which technologies to invest in, meet industry standards, compete against competitors.

Business Ecosystem Analysis

Advancements in technology and digitalization have changed the way companies do business; the concept of a business ecosystem helps businesses understand how to thrive in this changing environment. Business ecosystems provide organizations with opportunities to integrate technology in their daily business operations and improve research and business competency. The business ecosystem includes a network of interlinked companies that compete  and cooperate to increase sales, improve profitability, and succeed in their markets. An ecosystem analysis is a business network analysis that includes the relationships amongst suppliers, distributors, and end-users in delivering a product or service.


Get a Sample Copy of the Report @ https://www.marketdatacentre.com/sample/13497


Regions and Countries Covered

North America (US, Canada), Europe (Germany, UK, France, Spain, Italy, and Rest of Europe), Asia-Pacific (Japan, China, Australia, India, Rest of Asia-Pacific), and Rest of the World (RoW).

Report Coverage

Liquid Biopsy Market  Dynamics, Covid-19 Impact on the Liquid Biopsy Market , Vendor Profiles, Vendor Assessment, Strategies, Technology Assessment, Product Mapping, Industry Outlook, Economic Analysis, Segmental Analysis, Liquid Biopsy Market  Sizing, Analysis Tables.

About MDC:

Market Data Centre (Subsidiary of Yellow Bricks Global Services Private Limited)

Market Data Centre offers complete solutions for market research reports in miscellaneous businesses.These decisions making process depend on wider and systematic extremely important information created through extensive study as well as the most recent trends going on in the industry.The company also attempts to offer much better customer-friendly services and appropriate business information to achieve our clients’ ideas.

CONTACT: Market Data Centre (Subsidiary of Yellow Bricks Global Services Private Limited) Office 808, Amar Business Park, S.No. 105, Baner Road, Pune 411045, India Email: sales@marketdatacentre.com Phone: +1-916-848-6986 (US) Website: https://www.marketdatacentre.com/